Sreerama Shetty

Dr. Sreerama Shetty currently serves as a Professor at The University of Texas Health Science Center at Tyler (UTHCT). He has maintained continuous funding from the NIH and other foundations or other extramural funding agencies for the last 25 years. He is an internationally recognized authority in the investigation of mechanisms that govern lung scaring, has served on numerous grant panels, and is a frequent reviewer for high-impact journals in the field. Dr. Shetty was the principal investigator on five NIH-sponsored R01s and several other grants to study the role of the p53 system in the pathogenesis of lung epithelial injury and pulmonary fibrosis. This work led to the discovery of LTI-03, a novel potential treatment for idiopathic pulmonary fibrosis. D. Shetty has published more than 80 research papers related to lung injury and lung remodeling.